Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIME: Microplasmin in Uveitic Macular Edema
NCT01194674Phase 2Terminated
- Sponsor
- National Institutes of Health
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ocriplasmin in uveitic macular edema (UME), sponsored by National Institutes of Health. Started Jan 2011; status: terminated.
02
Drugs
ocriplasmin
03
Conditions
uveitic macular edema (UME)
Beyond the preview
Go deeper on NCT01194674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194674.